Literature DB >> 10743306

Primary pulmonary hypertension: update on pathogenesis and novel therapies.

A C Arroliga1, R A Dweik, F J Kaneko, S C Erzurum.   

Abstract

Primary pulmonary hypertension is a progressive and fatal disease that chiefly affects young adults. Although its etiology is a mystery, recent research has uncovered several biochemical derangements in this disorder, and new therapies are prolonging survival.

Entities:  

Mesh：

Year:  2000        PMID： 10743306     DOI： 10.3949/ccjm.67.3.175

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  3 in total

1.  Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension.

Authors:  Fares A Masri; Suzy A A Comhair; Iva Dostanic-Larson; Francisco Takao Kaneko; Raed A Dweik; Alejandro C Arroliga; Serpil C Erzurum
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

Review 2.  A review of pulmonary arterial hypertension: Part 1. Novel insights and classification.

Authors:  C T Gan; A Vonk Noordegraaf; K M J Marques; J G F Bronzwaer; P E Postmus; A Boonstra
Journal:  Neth Heart J       Date:  2004-06       Impact factor: 2.380

3.  Clinical and molecular findings in a family with the carbonic anhydrase II deficiency syndrome.

Authors:  Danny Lotan; Arik Eisenkraft; Jeffrey M Jacobsson; Omer Bar-Yosef; Robert Kleta; Nurit Gal; Lisa Raviv-Zilka; Hagar Gore; Yair Anikster
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.